CHMP4B (Charged Multivesicular Body Protein 4B) is a key component of the endosomal sorting complex required for transport III (ESCRT-III), which is vital for various cellular processes including multivesicular body (MVB) formation, viral budding, autophagy, and cytokinesis. The functional role of CHMP4B encompasses the recruitment and assembly of ESCRT-III complexes at sites where membrane remodeling and fission are necessary, such as the late endosomal membrane during MVB formation. This process is crucial for the downregulation and degradation of signaling receptors, thus playing a pivotal role in controlling signal transduction pathways and maintaining cellular homeostasis. CHMP4B, through its involvement in the ESCRT-III complex, ensures the proper segregation of cellular contents during division and the orderly degradation of cellular components, thereby facilitating cell renewal and response to stress.
The activation of CHMP4B is intricately regulated and involves several steps that ensure its timely recruitment and assembly into functional ESCRT-III complexes. Initially, the activation of CHMP4B is triggered by upstream signals that might include the ubiquitination of membrane proteins destined for degradation within MVBs. This post-translational modification serves as a cue for the recruitment of ESCRT-0, -I, and -II complexes to the endosomal membrane, which then facilitates the recruitment of CHMP4B as part of the ESCRT-III assembly. The transition of CHMP4B from an inactive cytosolic form to an active membrane-associated polymer involves autoinhibitory interactions that are relieved upon binding to upstream ESCRT components or specific phospholipids within the membrane. Furthermore, the activation of CHMP4B and its incorporation into the ESCRT-III complex is modulated by post-translational modifications and interactions with other ESCRT-III components, which promote conformational changes required for its function. The dynamic assembly and disassembly of CHMP4B-containing ESCRT-III complexes are critical for their function in membrane remodeling, highlighting the sophisticated regulatory mechanisms that control CHMP4B activation and ensuring the fidelity of cellular processes dependent on membrane fission and remodeling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor. Given the role of PI3K in vesicle trafficking, it can influence CHMP4B's activity indirectly. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Specific inhibitor of vacuolar-type H+-ATPase. Alters vesicular pH and can influence vesicle trafficking processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts endosomal-lysosomal trafficking, possibly affecting ESCRT functions and hence CHMP4B. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
Inhibitor of macropinocytosis, by affecting this pathway it can indirectly influence endosomal processes. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Clathrin inhibitor. Given clathrin's role in vesicular trafficking, it might have an indirect effect on CHMP4B. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A broad-spectrum tyrosine kinase inhibitor that can influence multiple pathways including vesicular trafficking. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubules, which play a role in vesicle trafficking, and can indirectly influence CHMP4B function. | ||||||